Endocrine responses during exercise-heat stress: effects of prior isotonic and hypotonic intravenous rehydration.
Exercise following exercise-induced dehydration (EID) has been shown to elevate concentrations of plasma norepinephrine (NE) and hypothalamic-pituitary-adrenal axis hormones. However, it is not known how intravenous (i.v.) rehydration (Rh) with isotonic (ISO) or hypotonic (HYPO) saline affects these hormone concentrations. It was hypothesized that HYPO, versus ISO, would lead to lower plasma NE and cortisol concentrations ([CORT]) during subsequent exercise following EID due to a decrease in plasma sodium concentration [Na+]. Eight non-heat acclimated men completed three experimental treatments (counterbalanced design) immediately following EID (33 degrees C) to -4% body mass loss. The Rh treatments were i.v. 0.9% NaCl (ISO, 25 ml x kg[-1]), i.v. 0.45% NaCl (HYPO, 25 ml x kg[-1]), and no fluid (NF). After Rh and rest (2 h total), the subjects walked at 53-54 percent of maximal O2 uptake for 45 min at 36 degrees C. After Rh, the following observations were made before/during exercise: percentage change in plasma volume (PV) was lower in NF compared to ISO and HYPO but similar between ISO and HYPO; delta[Na+] was similar between ISO and NF and higher in ISO compared to HYPO; delta plasma NE was higher in NF compared to ISO and HYPO, but similar between ISO and HYPO; delta plasma [CORT] was higher in NF compared to ISO and HYPO and higher in ISO compared to HYPO; rectal temperature was higher in NF compared to ISO and HYPO. These data would suggest that sympathetic nervous activity and [CORT] during exercise, subsequent to EID and Rh, was affected by lower PV (probably through cardiopulmonary baroreflexes) as well as core temperature. Furthermore, [CORT] was affected by delta[Na+] after Rh through an unknown mechanism.
Castellani
J W
JW
Department of Sport, Leisure, and Exercise Science, University of Connecticut, Storrs, USA.
Maresh
C M
CM
Armstrong
L E
LE
Kenefick
R W
RW
Riebe
D
D
Echegaray
M
M
Kavouras
S
S
Castracane
V D
VD
D000328:Adult; D001831:Body Temperature; D003681:Dehydration / Q000503:physiopathology / Q000628:therapy; D015444:Exercise / Q000502:physiology*; D006339:Heart Rate; D018882:Heat Stress Disorders; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007038:Hypotonic Solutions; D008297:Male; D009638:Norepinephrine / Q000097:blood*; D009994:Osmolar Concentration; D010101:Oxygen Consumption; D010953:Plasma Volume; D015532:Rehydration Solutions / Q000627:therapeutic use*; D012964:Sodium / Q000097:blood; D012965:Sodium Chloride / Q000008:administration & dosage / Q000627:therapeutic use*
D007038:Hypotonic Solutions; D015532:Rehydration Solutions; D012965:Sodium Chloride; D012964:Sodium; D006854:Hydrocortisone; D009638:Norepinephrine